Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection

Summary

In this prospective phase II observational study, we plan to assess the efficacy and tolerability of caspofungin based combined anti-fungal therapy for proven or probable IFI in a group of patients received allo-HSCT transplantation with high risk of IFI: HLA matched unrelated donor or mismatched donor conditioning with ATG containing regimen or present III-IV aGVHD or extensive GVHD undergoing high-dose steroid treatment.

Timeline

Start

2011-12

Primary completion

2017-06

Completion

2017-12

Drugs

Indications